Clinical trial · Interventional
Moderating the Negative Impact of Abnormal Screening Mammograms
NCT01153126CI-TRIAL-00013921completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project evaluates the impact of CHESS-Mammo by assessing participants' health information competence, psychological distress, and satisfaction with their doctor as measured by previously validated survey questionnaires.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Comprehensive Health Enhancement Support System (CHESS.) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- No Intervention: Usual Care
- description
- A group receiving usual care plus 5 reliable websites
- type
- EXPERIMENTAL
- label
- Intervention
- description
- A group using the Comprehensive Health Enhancement Support System (CHESS.)
- interventionNames
- Behavioral: Comprehensive Health Enhancement Support System (CHESS.)
Primary outcomes (1)
- measure
- This design will allow us to compare the health information competence, psychological distress, and patient satisfaction with their doctor among the two groups.
- timeFrame
- 3 weeks
- description
- This is a randomized controlled trial in which half of the participants will receive access to CHESS-Mammo during their diagnostic workup of an abnormal screening mammogram, and the other half will receive basic information in addition to usual care. This design will allow us to compare the health information competence, psychological distress, and patient satisfaction with their doctor among the two groups.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: To be eligible for the study, subjects must: * Be females at least 18 years of age, * Have had their screening mammogram performed at the UW Breast Center, * Be able to read and write English at the 6th grade level (as shown by their, ability to understand the informed consent), * Have access to a computer with internet capability. Exclusion Criteria: Exclusion Criteria: * Illiterate * Homeless
References
Publications (0)
Data not yet available
No reference posted for this study.